Clinical Trials · NCT02802514
A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- GlaxoSmithKline
- Enrollment
- 5
- Start date
- Sep 2016
- Locations
- 1 site, United States
- Primary endpoint
- Blood Oxygen Level Dependent (BOLD) Signal by Functional Magnetic Resonance Imaging (fMRI) Visual Nauseogenic Task